Overexpression of PARD3 maintained the self-renewal ability of the CD133 + TIC population within hepatocellular carcinoma (HCC) cells and promoted the in vitro and in vivo tumorigenicity of CD133 + TICs. This evidence concerns the gene PARD3 and hepatocellular carcinoma.